Medication info
Lansoton LFDT Tablet 15 mg (Lansoprazole)

Lansoton LFDT Tablet 15 mg (Lansoprazole)

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Lansoprazole›15mg / 1 tablet
Manufacturer / importer
Takeda Pharmaceuticals Korea CO., Ltd.
Appearance
The drug is a white to yellowish-white tablet with red to brown spots.
Packaging
100 tablets (10 tablets/PTP x 10), 98 tablets (7 tablets/PTP x 14)
Approval status
Active

MFDS item code 200510973 · Approved 2005.04.19 · Insurance code 696300120

Summary

Main use
Treatment and prevention of ulcers; treatment of reflux disease and gastric acid hypersecretion; Helicobacter pylori eradication therapy
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. Place this medicine on the tongue and allow it to dissolve in saliva before swallowing, or take it with water. Do not chew or crush this medicine before taking it. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The lansoprazole dose for pathological hypersecretory conditions varies among individual patients. The usual starting dose for adults is 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of up to 90 mg per dose twice daily have been administered. If the daily dose exceeds 120 mg, it should be divided. Because clearance of this medicine is decreased in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Use with caution, including dose adjustment, in patients with hepatic impairment because metabolism and excretion of this medicine may be delayed.
Child dose
Children and adolescents aged 12 ∼ 17 years: Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease — 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years: Short-term treatment of erosive reflux esophagitis — 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, weighing 30 kg or less: Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis — 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, weighing more than 30 kg: Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis — 30 mg once daily for 12 weeks

Ingredients

Importer
Takeda Pharmaceuticals Korea CO., Ltd.

Efficacy & effects

Treatment and prevention of ulcers; treatment of reflux disease and gastric acid hypersecretion; Helicobacter pylori eradication therapy

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion states.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It also helps eradicate Helicobacter pylori to prevent recurrence of duodenal ulcers. After treatment, it can be used for maintenance therapy to prevent recurrence of duodenal ulcers. It is effective in treating gastric ulcers caused by nonsteroidal anti-inflammatory drugs and reducing the risk of occurrence. It is also used for the short-term treatment of symptoms related to gastroesophageal reflux disease and erosive esophagitis, and for pathological hypersecretion states such as Zollinger-Ellison syndrome. It is widely used for various gastrointestinal diseases.

How to take

Adult dose

This medicine should be administered before meals. Place this medicine on the tongue and allow it to dissolve in saliva before swallowing, or take it with water. Do not chew or crush this medicine before taking it. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The lansoprazole dose for pathological hypersecretory conditions varies among individual patients. The usual starting dose for adults is 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of up to 90 mg per dose twice daily have been administered. If the daily dose exceeds 120 mg, it should be divided. Because clearance of this medicine is decreased in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Use with caution, including dose adjustment, in patients with hepatic impairment because metabolism and excretion of this medicine may be delayed.

Child dose

Children and adolescents aged 12 ∼ 17 years: Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease — 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years: Short-term treatment of erosive reflux esophagitis — 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, weighing 30 kg or less: Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis — 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, weighing more than 30 kg: Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis — 30 mg once daily for 12 weeks

Precautions

This drug contains the artificial sweetener aspartame and should not be taken by patients with the hereditary condition phenylketonuria. Patients with allergies to this drug or its components, or with hypersensitivity reactions to penicillin-type or macrolide antibiotics, should not use this medication. Pregnant women and patients with genetic issues such as lactose intolerance or galactose intolerance should avoid taking it. Patients with a history of drug allergies or reduced liver function, the elderly, breastfeeding women, and children should use this drug with caution. The drug may cause severe allergic reactions, blood abnormalities, liver dysfunction, or skin rashes; if symptoms occur, consult medical personnel immediately. Mild side effects such as headaches, diarrhea, abdominal pain, nausea, and vomiting have also been reported; symptoms should be carefully monitored. Long-term use may lead to vitamin B12 deficiency, hypomagnesemia, and increased fracture risk, necessitating regular check-ups. If gastric ulcers or malignant tumors are suspected, it should be used only after a proper diagnosis, and if side effects occur during treatment, the drug should be discontinued, and appropriate measures taken. There are many interactions with other drugs, so patients taking antibiotics, antivirals, anticoagulants, immunosuppressants, etc., should inform their doctor or pharmacist. Pregnant or breastfeeding women should not take this medication; if unavoidable, consult a specialist before making a decision. Children and elderly patients need dosage adjustments and careful observation; in case of overdose, seek medical attention immediately. Store this medication out of children's reach, and do not transfer it to another container for safety.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, dyspnea, abnormal lung sounds, interstitial nephritis, acute kidney failure, membranous colitis, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, neoplasm, chills, chest pain, swelling, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, shock, vasodilation, syncope, abnormal stool, enteritis, gastritis, gastric abnormalities, gastrointestinal disease, gastrointestinal bleeding, decreased appetite, bezoar, pyloric spasm, cholelithiasis, constipation, polydipsia, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, bloating, gastric nodules, gastric fundic polyps, gastroenteritis, upper gastrointestinal bleeding, hematemesis, increased appetite, increased salivation, anal bleeding, stomatitis, glossitis, gum bleeding, postprandial syndrome, colitis, vomiting, nausea, gastric candidiasis, rectal disease, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disease, joint disease, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia gravis, ptosis, synovitis, anxiety, memory loss, anxiety, apathy, confusion, depression, dizziness, syncope, hallucinations, unilateral paralysis, worsening hostility, decreased libido, increased libido, neurosis, sensory abnormalities, abnormal thinking, seizures, dementia, derealization, diplopia, hyperkinesia, hypertonia, sensory deprivation syndrome, insomnia, sleep disturbances, drowsiness, tremor, asthma, bronchitis, increased cough, dyspnea, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, olfactory dysfunction, photophobia, retinal degeneration, taste loss, blurred vision, deafness, ocular pain, otitis media, taste disorder, tinnitus, visual field constriction, voiding dysfunction, renal pain, penile disorders, testicular disorders, urethral pain, polyuria, frequency of urination, post-void residual urine, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, pancreatitis, taste alteration, aplastic anemia, leukopenia, neutropenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, hypocalcemia, hypokalemia, hyponatremia, Clostridium difficile-associated diarrhea, fractures, myositis, erythema multiforme, acute generalized exanthematous pustulosis, systemic lupus erythematosus, cutaneous lupus erythematosus, speech disorders, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, malaise, hyponatremia, elevated total cholesterol, decreased total cholesterol, positive urinary protein, positive urinary glucose, fatigue, abdominal pain, bowel movement changes, abdominal bloating, heartburn, gastroesophageal reflux, stomatitis, glossitis, polydipsia, headache, drowsiness, insomnia, paralysis, depressive state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. This helps maintain the drug's effectiveness.

Appearance and packaging

Appearance

The drug is a white to yellowish-white tablet with red to brown spots.

Package unit

100 tablets (10 tablets/PTP x 10), 98 tablets (7 tablets/PTP x 14)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.